Fortitude Family Office’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9K Sell
85
-2
-2% -$429 ﹤0.01% 560
2026
Q1
$19.2K Buy
87
+20
+30% +$4.89K ﹤0.01% 441
2025
Q4
$17K Buy
67
+2
+3% +$502 ﹤0.01% 441
2025
Q3
$16.1K Sell
65
-2
-3% -$479 ﹤0.01% 444
2025
Q2
$16.1K Buy
67
+13
+24% +$3.03K 0.01% 423
2025
Q1
$12.2K Hold
54
﹤0.01% 492
2024
Q4
$11.1K Hold
54
﹤0.01% 604
2024
Q3
$13.1K Buy
54
+6
+13% +$1.4K 0.01% 513
2024
Q2
$10.5K Hold
48
0.01% 409
2024
Q1
$10.8K Hold
48
0.01% 381
2023
Q4
$10.6K Buy
+48
New +$10.2K 0.01% 395

Other funds holding STE

Fortitude Family Office's STE Position: Q2 2026 in Review

Fortitude Family Office reduced its Steris (STE) stake by 2.3% in Q2 2026, selling an estimated $429 and leaving 85 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Fortitude Family Office first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.2K in Q1 2026. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Fortitude Family Office held 85 shares of Steris worth $17.9K as of Q2 2026.
  • Fortitude Family Office sold 2 Steris shares in Q2 2026, an estimated $429.
  • Steris made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #560 holding.
  • Fortitude Family Office first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Steris position peaked at $19.2K in Q1 2026.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.